Medtronic to Acquire Scientia Vascular for $550m, Targeting $100m Neuro Guidewire Market
Medtronic will acquire Utah-based Scientia Vascular for $550m, inheriting access microcatheters and guidewires to expand its neurovascular portfolio worldwide, with potential earn‐outs post-close in fiscal 2027. The purchase follows a $585m CathWorks deal and could lift neuro micro guidewire sales by an incremental $45m, targeting global revenue of $80m-100m.
1. Deal Overview
Medtronic agreed to acquire Utah-based Scientia Vascular for $550m, securing a portfolio of access microcatheters and micro guidewires, with undisclosed earn-out and milestone payments upon closing.
2. Strategic Expansion
The acquisition bolsters Medtronic’s neurovascular business with a full suite of products designed for haemorrhagic and acute ischemic stroke interventions, enhancing procedural speed and reliability.
3. Market and Financial Impact
Scientia’s current neuro micro guidewire revenue of $45m will complement Medtronic’s $849m category sales, in a global interventional neuroradiology market projected to grow at an 8.6% CAGR to $9.8bn by 2035.
4. Outlook and Timeline
The deal is expected to close in the first half of fiscal 2027 as Medtronic’s second major acquisition this year, aiming to drive $80m-100m in incremental guidewire sales globally.